Trial intelligence / Profile preview

Amiloride in Coronary Heart Disease

NCT01231165Phase 3Completed

Sponsor
Universidad de Carabobo
Start
Feb 2009
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of amiloride in coronary heart disease (CHD), sponsored by Universidad de Carabobo. Started Feb 2009; status: completed.

02

Drugs

amiloride
03

Conditions

coronary heart disease (CHD)

Beyond the preview

Go deeper on NCT01231165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01231165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call